What is LOPJLB’s current signal on COLL?

LOPJLB’s latest quantitative signal on Collegium Pharmaceutical, Inc. (COLL) is SELL in a BEAR regime. Signals are updated daily.

What market regime is COLL in?

Collegium Pharmaceutical, Inc. (COLL) is currently classified in the BEAR HMM market regime on LOPJLB.

Collegium Pharmaceutical, Inc. (COLL)

COMPARE

Healthcare · Drug Manufacturers - Specialty & Generic · NASDAQ · US

$21.53-2.36%Close

SELLBEAR · day 12

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONECOIL

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $698M
Beta: 0.73
P/E (TTM): 14.07

Short % float: 17.21%
Days to cover: 6.1
SI change: -2.8%

1W: -1.60%
1M: -5.61%

vs SPY 1W: -1.46%
vs SPY 1M: -8.12%

Industry peers

FMP comparable companies · ranked by market cap

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Collegium Pharmaceutical, Inc. (COLL) is a specialized pharmaceutical firm dedicated to the development and marketing of medications for pain management. Its diverse product lineup features significant therapies aimed at addressing various pain conditions. A prominent offering…

Employees: 423
Headquarters: US
Founded: 2015
Exchange: NASDAQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Shares out: 32.4M
Float: 98.8%

collegiumpharma.com ↗

Key executives

Vikram Karnani — President, Chief Executive Officer & Director

Colleen Tupper — Executive Vice President & Chief Financial Officer

Thomas Smith FAAFP — Executive Vice President & Chief Medical Officer

SEC filings

EDGAR · CIK 12675650 · COLL

Analyst consensus

Buy

Bullish866.7%

Neutral325.0%

Bearish18.3%

L $45.00Avg $48.00H $50.00

Target$48.00+122.94%

Last$21.53

FAQ

What is LOPJLB’s current signal on COLL?: LOPJLB’s latest quantitative signal on Collegium Pharmaceutical, Inc. (COLL) is SELL in a BEAR regime. Signals are updated daily.
What market regime is COLL in?: Collegium Pharmaceutical, Inc. (COLL) is currently classified in the BEAR HMM market regime on LOPJLB.
What does Collegium Pharmaceutical, Inc. (COLL) do?: Collegium Pharmaceutical, Inc. (COLL) is a specialized pharmaceutical firm dedicated to the development and marketing of medications for pain management. Its diverse product lineup features significant therapies aimed at addressing various pain conditions. A prominent offering is Xtampza ER, an extended-release, oral formulation of oxycodone, specifically engineered with properties to deter abu…

Key stats

Industry peers

Prediction markets

Company news

FAQ